LncSNHGs:在骨髓瘤中的新目标
Yining Zhang1,2, Jinfa Wu1,3, Jiaming Liu4,5
1Department of Orthopaedic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, PR China.
Cancer gene therapy
|August 16, 2025
概括
小核RNA宿主基因 (SNHGs) 中的长非编码RNA (lncRNAs) 在骨髓瘤 (OS) 发育中至关重要. 失调的SNHG表达影响瘤生长,转移和治疗,为OS提供新的诊断和治疗点.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 长非编码RNAs (lncRNAs) 是癌症生物学中的关键调节者.
- 骨髓瘤 (OS) 是一种具有复杂遗传基础的原发性骨恶性瘤.
- 小核RNA宿主基因 (SNHGs) 是一种涉及各种癌症的lncRNA家族.
研究的目的:
- 提供关于骨髓瘤中lncRNA SNHG家族的全面综述.
- 阐明SNHG在OS中的生物学作用和分子机制.
- 总结OS中SNHG的表达模式和临床相关性.
主要方法:
- 文献综述和对SNHGs在骨髓瘤中的现有研究的分析.
- 检查OS中SNHG功能背后的分子机制.
- 对SNHG表达的数据的综合及其与OS进展的相关性.
主要成果:
- SNHG家族成员在骨髓瘤组织中表达的变化.
- 失调的SNHG会影响诸如扩散,转移和亡之类的关键瘤性过程.
- 在OS中,SNHG与化学抵抗和自细胞调节有关.
结论:
- lncRNA SNHG家族代表了骨髓瘤的重要研究领域.
- 在OS病变发生过程中,SNHGs扮演着多方面的角色,影响瘤生长和治疗反应.
- 准SNHG可能为骨髓瘤提供新的诊断,预后和治疗策略.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


